Injectable Drug Delivery Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 2306 | Published Date: Oct 2024 | No. of Page: 130 | Base Year: 2023 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL INJECTABLE DRUG DELIVERY INDUSTRY
    2.1 Summary about Injectable Drug Delivery Industry
    2.2 Injectable Drug Delivery Market Trends
        2.2.1 Injectable Drug Delivery Production & Consumption Trends
        2.2.2 Injectable Drug Delivery Demand Structure Trends
    2.3 Injectable Drug Delivery Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 Analgesics
        4.2.2 Antibiotics
        4.2.3 Immunosuppressive Agents
        4.2.4 Antihypertensive Agents
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Aesthetics
        4.3.2 Autoimmune Diseases
        4.3.3 Hormonal Disorders
        4.3.4 Infectious Diseases
        4.3.5 Oncology
        4.3.6 Pain Management
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 Analgesics
        5.2.2 Antibiotics
        5.2.3 Immunosuppressive Agents
        5.2.4 Antihypertensive Agents
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Aesthetics
        5.3.2 Autoimmune Diseases
        5.3.3 Hormonal Disorders
        5.3.4 Infectious Diseases
        5.3.5 Oncology
        5.3.6 Pain Management
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 Analgesics
        6.2.2 Antibiotics
        6.2.3 Immunosuppressive Agents
        6.2.4 Antihypertensive Agents
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Aesthetics
        6.3.2 Autoimmune Diseases
        6.3.3 Hormonal Disorders
        6.3.4 Infectious Diseases
        6.3.5 Oncology
        6.3.6 Pain Management
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 Analgesics
        7.2.2 Antibiotics
        7.2.3 Immunosuppressive Agents
        7.2.4 Antihypertensive Agents
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Aesthetics
        7.3.2 Autoimmune Diseases
        7.3.3 Hormonal Disorders
        7.3.4 Infectious Diseases
        7.3.5 Oncology
        7.3.6 Pain Management
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 Analgesics
        8.2.2 Antibiotics
        8.2.3 Immunosuppressive Agents
        8.2.4 Antihypertensive Agents
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Aesthetics
        8.3.2 Autoimmune Diseases
        8.3.3 Hormonal Disorders
        8.3.4 Infectious Diseases
        8.3.5 Oncology
        8.3.6 Pain Management
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 Analgesics
        9.2.2 Antibiotics
        9.2.3 Immunosuppressive Agents
        9.2.4 Antihypertensive Agents
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Aesthetics
        9.3.2 Autoimmune Diseases
        9.3.3 Hormonal Disorders
        9.3.4 Infectious Diseases
        9.3.5 Oncology
        9.3.6 Pain Management
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Becton
        10.1.2 Dickinson and Company
        10.1.3 Baxter International
        10.1.4 Gerresheimer
        10.1.5 Pfizer
        10.1.6 Schott
        10.1.7 Sandoz
        10.1.8 Teva Pharmaceutical Industries
        10.1.9 Eli Lilly and Company
        10.1.10 Antares Pharma
        10.1.11 Eli Lilly & Company
        10.1.12 Hospira
        10.1.13 Novo Nordik
        10.1.14 Sanofi
        10.1.15 Terumo Corporation
        10.1.16 Unilife Corporation
        10.1.17 Zogenix
        10.1.18 Scandinavian Health
    10.2  Injectable Drug Delivery Sales Date of Major Players (2017-2020e)
        10.2.1 Becton
        10.2.2 Dickinson and Company
        10.2.3 Baxter International
        10.2.4 Gerresheimer
        10.2.5 Pfizer
        10.2.6 Schott
        10.2.7 Sandoz
        10.2.8 Teva Pharmaceutical Industries
        10.2.9 Eli Lilly and Company
        10.2.10 Antares Pharma
        10.2.11 Eli Lilly & Company
        10.2.12 Hospira
        10.2.13 Novo Nordik
        10.2.14 Sanofi
        10.2.15 Terumo Corporation
        10.2.16 Unilife Corporation
        10.2.17 Zogenix
        10.2.18 Scandinavian Health
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
1.Table Injectable Drug Delivery Product Type Overview
2.Table Injectable Drug Delivery Product Type Market Share List
3.Table Injectable Drug Delivery Product Type of Major Players
4.Table Brief Introduction of Becton
5.Table Brief Introduction of Dickinson and Company
6.Table Brief Introduction of Baxter International
7.Table Brief Introduction of Gerresheimer
8.Table Brief Introduction of Pfizer
9.Table Brief Introduction of Schott
10.Table Brief Introduction of Sandoz
11.Table Brief Introduction of Teva Pharmaceutical Industries
12.Table Brief Introduction of Eli Lilly and Company
13.Table Brief Introduction of Antares Pharma
14.Table Brief Introduction of Eli Lilly & Company
15.Table Brief Introduction of Hospira
16.Table Brief Introduction of Novo Nordik
17.Table Brief Introduction of Sanofi
18.Table Brief Introduction of Terumo Corporation
19.Table Brief Introduction of Unilife Corporation
20.Table Brief Introduction of Zogenix
21.Table Brief Introduction of Scandinavian Health
22.Table Products & Services of Becton
23.Table Products & Services of Dickinson and Company
24.Table Products & Services of Baxter International
25.Table Products & Services of Gerresheimer
26.Table Products & Services of Pfizer
27.Table Products & Services of Schott
28.Table Products & Services of Sandoz
29.Table Products & Services of Teva Pharmaceutical Industries
30.Table Products & Services of Eli Lilly and Company
31.Table Products & Services of Antares Pharma
32.Table Products & Services of Eli Lilly & Company
33.Table Products & Services of Hospira
34.Table Products & Services of Novo Nordik
35.Table Products & Services of Sanofi
36.Table Products & Services of Terumo Corporation
37.Table Products & Services of Unilife Corporation
38.Table Products & Services of Zogenix
39.Table Products & Services of Scandinavian Health
40.Table Market Distribution of Major Players
41.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
42.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
43.Table Global Injectable Drug Delivery Market Forecast (Million USD) by Region 2021f-2026f
44.Table Global Injectable Drug Delivery Market Forecast (Million USD) Share by Region 2021f-2026f
45.Table Global Injectable Drug Delivery Market Forecast (Million USD) by Demand 2021f-2026f
46.Table Global Injectable Drug Delivery Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Injectable Drug Delivery Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Injectable Drug Delivery Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Injectable Drug Delivery Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Injectable Drug Delivery Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Injectable Drug Delivery Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Injectable Drug Delivery Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Injectable Drug Delivery Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Analgesics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Immunosuppressive Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Antihypertensive Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Aesthetics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Infectious Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Pain Management Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Analgesics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Immunosuppressive Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Antihypertensive Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Aesthetics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Infectious Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Pain Management Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Analgesics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Immunosuppressive Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Antihypertensive Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Aesthetics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Infectious Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Pain Management Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Analgesics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Immunosuppressive Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Antihypertensive Agents Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Aesthetics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Autoimmune Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Hormonal Disorders Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Infectious Diseases Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Oncology Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Pain Management Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Analgesics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Antibiotics Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure Immunosuppressive Agents Segmen
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Injectable Drug Delivery Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Injectable Drug Delivery Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Injectable Drug Delivery Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports